US Patent 7238813 Chemical compounds
Patent 7238813 was granted and assigned to Smithkline Beecham Limited on July, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 18 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Infobox
Patent Inventor Names
Hideyuki Sato0
James Marvin Veal0
Kazuya Kano0
Masaichi Hasegawa0
Mui Cheung0
Naohiko Nishigaki0
Philip Anthony Harris0
Rob I. West0
Satoru Ida0
Yoshiaki Washio0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+287 characters)
Article
Patent abstract
Benzimidazole derivatives, which are useful as TIE-2 and/or VEGFR2 inhibitors are described herein. The described invention also includes methods of making such benzimidazole derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07238813 Chemical compounds US Patent 7238813 Chemical compounds
Infobox
Patent Number
072388130
Patent Number
72388130
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072388130
Date of Patent
July 3, 2007
0Patent Application Number
104331280
Date Filed
November 28, 2001
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07238813 Chemical compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07238813
Date of patent
July 3, 2007
Patent application number
10433128
Date Filed
November 28, 2001
Patent primary examiner
Find more entities like US Patent 7238813 Chemical compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
